share this news:
Posted by Heidi Schwartz
Æterna Zentaris Inc., a biopharmaceutical company, has announced that it has selected Charleston, SC as its new location for the company’s North American business and global commercial operations. Over the next five years, Æterna Zentaris is expected to implement a staff to support the areas of commercial operations, business development, regulatory and quality assurance, manufacturing management, clinical and product development, as well as various administrative functions. In conjunction with the Company’s plans and commitment to this investment, the Coordinating Council for Economic Development of South Carolina has approved job development credits to Æterna Zentaris.
David Dodd, President and CEO at Æterna Zentaris commented, “The Charleston area is one of the most thriving and exciting business communities in the United States and we are very much looking forward to becoming part of it. This marks an important milestone in Æterna Zentaris’ transition from an R&D company into a commercially operating company. As we evaluated our options, we were highly impressed by the commitment to life sciences demonstrated by the leadership of South Carolina and the emergence of Charleston as a collaborative center for research and development in the biopharmaceutical industry. We especially want to thank and acknowledge the leadership within the South Carolina Research Authority, the South Carolina Department of Commerce, the Charleston Regional Development Alliance and the team at the Medical University of South Carolina, all of whom contributed to this significant decision for our corporation. Finally, we wish to thank Governor Nikki Haley, who personally conveyed the state’s commitment to assisting companies such as Æterna Zentaris, in successfully developing the bio-industry throughout South Carolina.”
Nikki Haley, Governor of South Carolina stated, “We are excited Æterna Zentaris chose Charleston to be the home of their new North American business and global commercial operations – further proof that South Carolina is attracting cutting-edge research and development. We celebrate their decision to invest and to create new jobs in the Charleston area.”